Normal physiological responses to carbohydrate shortages cause the liver to increase the production of ketone bodies from the acetyl-CoA generated from fatty acid oxidation. This allows the use of ketone bodies for energy, thereby preserving the limited glucose for use by the brain. This adaptative response is switched off by insulin rapidly inhibiting the expression of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) synthase (HMGCS2) gene, which is a key control site of ketogenesis. We decided to investigate the molecular mechanism of this inhibition. In the present study, we show that FKHRL1, a member of the forkhead in rhabdosarcoma (FKHR) subclass of the Fox family of transcription factors, stimulates transcription from transfected 3-hydroxy-3-methylglutaryl-CoA synthase promoter-
INTRODUCTION
Mitochondrial 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) synthase (HMGCS2), which catalyses the condensation of acetylCoA with acetoacetyl-CoA to form HMG-CoA and CoA in mitochondria, is a key control site of ketogenesis in various hormonal and metabolic situations [1] [2] [3] [4] . Thus its mRNA levels rapidly vary according to cAMP, insulin and dexamethasone and greatly increase both in response to starvation, fat-feeding and diabetes and during the early neonatal period [5] [6] [7] [8] [9] .
To explore the control of the HMGCS2 gene, we examined its transcriptional regulation. Transient transfection experiments and testing of transgenic mice have revealed that a 1149 bp fragment of the 5h-flanking region contains the elements responsible for the multi-hormonal regulation of transcription of this gene [10, 11] . The HMGCS2 gene promoter contains a peroxisome proliferator-activated receptor-responsive element, and the activation of HMGCS2 gene expression by fatty acids may be mediated by this receptor [12] . In addition, the enhanced expression of the gene in the liver of starved rats, newborn rats, suckling rats and fat-fed rats may result from the high plasma glucagon and the low plasma insulin levels that prevail in these situations.
In Type I diabetes, stimulated gluconeogenesis consumes most of the available oxaloacetate, but breakdown of fat produces large amounts of acetyl-CoA. This increased acetyl-CoA is normally directed into the tricarboxylic acid cycle, but since oxaloacetate is in short supply, it is used for excess production of ketone bodies. We thus focused on the molecular mechanism by which insulin inhibits the HMGCS2 gene.
This process is only partially understood. Members of the FKHR (forkhead in rhabdosarcoma) subclass of the Fox family Abbreviations used : CAT, chloramphenicol acetyltransferase ; ChIP, chromatin immunoprecipitation ; EMSA, electrophoretic mobility-shift assay; FKHR, forkhead in rhabdosarcoma (a transcription factor) ; HMG-CoA, 3-hydroxy-3-methylglutaryl-CoA ; HMGCS2, mitochondrial HMG-CoA synthase ; IGF, insulin-like growth factor ; IGFBP, IGF-binding protein ; IRE, insulin response element ; IRS, insulin response sequence ; mTOR, mammalian target of rapamycin ; PI-3K, phosphoinositide 3-kinase ; PKB, protein kinase B ; TKLUC, thymidine kinase luciferase. 1 To whom correspondence should be addressed (e-mail dharo!farmacia.far.ub.es).
luciferase reporter constructs, and that this stimulation is repressed by insulin. An FKHRL1-responsive sequence AAAAATA, located 211 bp upstream of the HMGCS2 gene transcription start site, was identified by deletion analysis. It binds FKHRL1 in i o and in itro and confers FKHRL1 responsiveness on homologous and heterologous promoters. If it is mutated, it partially blocks the effect of insulin in HepG2 cells, both in the absence and presence of overexpressed FKHRL1. These results suggest that FKHRL1 contributes to the regulation of HMGCS2 gene expression by insulin.
Key words : gene expression, ketogenesis.
of transcription factors, such as FKHRL1, are involved in the regulation of gene expression by insulin. This family has been the subject of research after genetic complementation studies of Caenorhabditis elegans identified the Daf-16 gene as a target of the protein kinase B (PKB)\Akt kinase [13] . The Daf-16 gene belongs to the forkhead family of transcription factors and FKHR proteins are the closest mammalian homologues of the Daf-16 gene product [13] [14] [15] . They are phosphorylated by PKB\Akt and regulated by phosphorylation in an insulindependent or insulin-like growth factor I (IGF-I)-dependent manner [16, 17] . FKHR binds to forkhead-binding sites within the previously identified insulin response element (IRE) of the IGF-binding protein 1 (IGFBP-1) promoter and stimulates promoter activity. This stimulation is suppressed by insulin via phosphorylation of FKHR by PKB [18] [19] [20] [21] [22] [23] ; furthermore, it has been found that the kinase mammalian target of rapamycin (mTOR) is required for full insulin regulation of IGFBP-1 gene transcription [24] . Signalling by PKB to forkhead proteins can also partially account for the regulation of glucose-6-phosphatase [25] or phosphoenolpyruvate carboxykinase [26] promoter activity by insulin.
In the present study, we identify an FKHRL1-responsive sequence located 211 bp upstream of the HMGCS2 gene transcription start site. This sequence binds to FKHRL1 both in i o and in itro and confers FKHRL1 responsiveness on homologous and heterologous promoters, and its mutation in the context of the HMGCS2 promoter partially abolished the insulin-mediated inhibition of the transcriptional activity of this promoter in HepG2 cells. We also demonstrate that the HMGCS2 gene repression by insulin involves the participation of the phosphoinositide 3-kinase (PI-3K)\PKB transduction pathway.
EXPERIMENTAL Plasmids
Reporter chloramphenicol acetyltransferase (CAT) construct pSMpCAT1 contains 1148 bp of the 5h-flanking region and the first 28 bp of exon 1 of the rat HMGCS2 gene in the pCAT-BASIC vector (Promega), and has been described previously [10] . PGL3SM1 was constructed by subcloning the k1148 to j28 fragment of pSMpCAT1, obtained by Sal I digestion and fill-in, into the pGL3-BASIC firefly luciferase reporter gene (Promega), digested by SmaI. pSMpCAT3, pSMpCAT5, pSMpCAT116 and pSMpCAT62 contained progressively smaller fragments of the 5h-flanking region and the same 3h-end point in exon 1 (j28) of the gene as reported elsewhere [12, 27] . Mutant pGL3SM1-IRSmut (where IRS is the insulin response sequence) was generated from pGL3SM1, in which the IRE element was mutated by site-directed mutagenesis using overlap-extension PCR [28] . pGL3SM1 (100 ng) was used as a target in two independent PCR reactions (94 mC, 1 min ; 55 mC, 1 min ; 72 mC, 1 min ; 10 cycles). For the first PCR, 5h-CCACAGATGCA-TACACATAGG-3h, which corresponds to co-coordinates k828 to k808, was used as a forward primer and 5h-TTGTTAGCCTctgcagTGGCTAGCCATGCAAG-3h, which corresponds to coordinates k226 to k195 was used as a reverse primer ; here, the nucleotides in lower-case letters correspond to those that have been changed from the wild-type sequence. For the second PCR, the forward primer was 5h-ATGGCTAGCCActgcagA-GGCTAACAAGGAAG-3h, which corresponds to coordinates k221 to k190 and the reverse primer was 5h-CTTAGCG-AGGCCTCTGCCTG-3h, which corresponds to coordinates k59 to k79. In the subsequent overlap-extension reaction, 200 ng of each PCR product was used as a target and the oligonucleotides corresponding to coordinates k828 to k808 and k59 to k79 were used as forward and reverse primers respectively (94 mC, 1 min ; 55 mC, 2 min ; 72 mC, 1 min ; 10 cycles). The PCR product was cloned in the p-GEM-T vector and subsequently digested by Mph1103I (A aIII) and StuI, thus generating an 800 bp fragment, which was subcloned into pGL3SM1∆800, which corresponded to the plasmid pGL3SM1 previously digested by the same endonucleases, generating the pGL3SM-IRSmut. The IRS-thymidine kinase luciferase (TKLUC) plasmid was constructed by cloning the oligonucleotide 5h-agcttATGGCTAGCCAAAAATAAGGCTAAC-AAG-3h (corresponding to coordinates k221 to k195 of the rat HMGCS2 gene) annealed to 5h-tcgacTTGTTAGCCTTATT-TTTGGCTAGCCATA (corresponding to coordinates k221 to k195). The nucleotides designated in lower case were added to provide cohesive HindIII-Sal I ends at the 5h-and 3h-termini respectively. pcDNA3-FKHRL1 and pcDNA3-FKHRL1TM (FKHRL1TM, a mutant version of FKHRL1 in which the residues Thr$#, Ser#&$ and Ser$"& have been changed to Ala) were constructed by subcloning the HindIII-XbaI fragments from the pECE HA-FKHRL1 wild-type and pECE HA-FKHRL1TM plasmids [16] into pcDNA3. Both strand sequences of all plasmids were confirmed by the dideoxynucleotide chain-termination method [29] using an automated fluorescence-based system (Applied Biosystems, Warrington, Cheshire, U.K.).
Cell culture and transfections
HepG2 cells were cultured and transfected in Minimal Essential Medium supplemented with 10 % foetal calf serum ; typically, 5i10& cells were co-transfected with 5 µg of the reporter HMGCS2-CAT or luciferase gene constructs, 0.5 µg of an expression vector for the insulin receptor B and, where indicated, 1 µg of effector plasmid expressing full-length cDNA for the FKHRL1 (pECE-FKHRL1) or FKHRL1TM (pECE-FKHR-L1TM) transcription factors, or the wild-type or a kinaseinactive (kinase dead) form of PKB. In all luciferase experiments, 50 ng of pRL plasmid (cytomegalovirus promoter-Renilla luciferase) was included as an internal control. Transfection experiments were performed by the calcium phosphate method as described elsewhere [30, 31] . After 8-10 h, the calcium phosphate-DNA precipitate was removed and cells were incubated with serum-free Dulbecco's modified Eagle's medium supplemented with 1 g\l fatty acid-free bovine albumin (A-9205 ; Sigma) and harvested for 18-20 h after refeeding. When necessary, bovine pancreas insulin (I-6634 ; Sigma), LY294002 (440202 ; Calbiochem, Bad Soden, Germany) or wortmannin (681675 ; Calbiochem) were added after removing the precipitate.
Luciferase, Bradford and CAT assays
For CAT assays, extracts of harvested cells were prepared by liquid nitrogen freeze-thaw disruption (three times) after resuspension in 50 µl of 0.25 M Tris\HCl (pH 7.5). All samples assayed for CAT activity were first incubated at 65 mC for 5 min. CAT assays were performed for 60 min by the method described previously [30] . Radioactivity of the samples was measured on an LKB-1217 liquid-scintillation counter. For luciferase assays, the cells were harvested by passive lysis and then luciferase assays were performed using the Dual Luciferase Reporter Assay System (Promega) according to the manufacturer's instructions. Luciferase activity was measured using TD-20\20 Luminometer (Turner Designs, Inc., Sunnyvale, CA, U.S.A.). Protein content was quantified following the method of Bradford [32] . Both protein quantification and Renilla luciferase activity analysis were used to normalize transfection efficiency.
In vitro transcription/translation
cDNA for FKHRL1 was transcribed and translated directly (in rabbit reticulocyte lysate) from 1 µg of pCDNA3-FKHRL1 by using a kit (Promega) according to the manufacturer's instructions. To obtain an unprogrammed lysate as a negative control for the electrophoretic mobility-shift assay (EMSA), a translation reaction was performed with 1 µg of pcDNA3.
EMSA FKHRL1 (5 µl) synthesized in itro was preincubated on ice for 10 min in 10 mM Tris\HCl (pH 7.5), 80 mM KCl, 4 % glycerol, 1 mM 2-mercaptoethanol, 1 mM EDTA and 2 µg of poly(dI\ dC). The total amount of reticulocyte lysate (5 µl) was kept constant in each reaction by the addition of unprogrammed lysate. IRS refers to a pair of oligonucleotides containing the fragment corresponding to coordinates k221 to k195 of the rat HMGCS2 gene ; IRSmut is the same fragment but with the proposed IRS mutated. Next, 4 ng of either IRS or IRSmut, $#P-labelled by fillin with the Klenow polymerase, was added, and the incubation was continued for 20 min at room temperature. For competition experiments, a 50-, 100-and 200-fold molar excess of IRS, relative to the labelled probe, was included during preincubation. For the supershift assay, 1 µl of specific FKHRL1 antibody (sc-9813 ; Santa Cruz) was added to the reaction mixture 10 min after the labelled probe. The final volume for all reactions was 20 µl. Samples were electrophoresed at 4 mC on non-denaturing 4.5 % (w\v) polyacrylamide gel in 0.5 % TBE buffer (45 mM Tris\45 mM boric acid\1 mM EDTA ; pH 8.0). Down-regulation of the HMGCS2 gene by insulin
Chromatin immunoprecipitation (ChIP) assays
Cross-linking between transcription factors and chromatin was achieved in H4IIE cells by adding formaldehyde (final concentration of 1 %) to the culture medium for 10 min. The reaction was stopped by adding glycine at a final concentration of 0.125 M, and the cells were washed three times with cold PBS. Cells were then scraped in PBS, centrifuged and washed twice with PBS containing 1 mM PMSF. The pellets were re-suspended in 2 ml of cell lysis buffer [5 mM Pipes (KOH), pH 8.0\85 mM KCl\ 0.5 % (v\v) Nonidet P40] in the presence of protease inhibitors (100 mg\ml leupeptin, 100 ng\ml aprotinin and 1 mM PMSF). Samples were incubated on ice for 10 min and subjected to 10 strokes in a Dounce homogenizer. Nuclei were collected by centrifugation at 250 g for 10 min, and the supernatant was discarded. Nuclear pellets were re-suspended in 0.2 ml of nuclear lysis buffer [50 mM Tris (pH 8.0)\10 mM EDTA\1 % (w\v) SDSjprotease inhibitors] and sonicated at full power for four 10 s pulses to shear the chromatin to an average length of 2 kb. Samples were then diluted by 10-fold with the immunoprecipitation dilution buffer [1 % (v\v) Triton X-100\16.7 mM Tris (pH 8)\1.2 mM EDTA\167 mM NaCl plus the protease inhibitors]. To reduce the non-specific binding, samples were incubated with 80 µl of salmon sperm DNA\Protein G-Sepharose slurry (Sigma) at 4 mC for 1 h on a rotating wheel, and beads were collected by centrifugation at 500 g for 1 min. Precleared chromatin solutions were incubated either with 15 µg of human FKHRL1 antibody (Santa Cruz) or with no antibody and rotated overnight at 4 mC. Immune complexes were collected after the addition of 80 µl of salmon sperm DNA\Protein G-Sepharose slurry (Sigma) for 4 h with rotation. Samples were then washed four times with 1 ml of wash buffer [0.1 % (v\v) Triton X-100\ 20 mM Tris (pH 8.0)\150 mM NaCl\2 mM EDTA] and eluted by performing three successive 5 min incubations with 150 µl of elution buffer [1 % (v\v) SDS\50 mM NaHCO $ ]. The eluates were pooled, NaCl was added at a final concentration of 0.3 M and the samples were incubated at 65 mC for 4 h to reverse the formaldehyde-induced cross-linking. Digestion buffer [10 µl of 2 M Tris (pH 6.8)\10 µl of 0.5 M EDTA\2 µl of proteinase K (20 mg\ml)] was added, and the samples were placed at 45 mC for 2 h. Chromatin DNA was extracted with phenol\chloroform followed by ethanol precipitation. DNA was re-suspended in 50 µl of sterile water, and a 5 µl aliquot was used for PCR analysis. Primers for the amplification of the 291 bp fragment from coordinates k346 to k55 of the HMGCS2 promoter, containing the IRS, were : (1) 5h-ACCACCAGGCAGTACAAG-TG-3h and (2) 5h-TCCACTTAGCGAGGCCTCTG-3h. Following amplification, the PCR products were electrophoresed in a 2 % agarose gel and visualized by ethidium bromide staining.
Western-blot assays
The total extract of control, insulin-and LY294002-treated HepG2 cells was separated by SDS\PAGE (10 % gel) and transferred on to a nitrocellulose membrane. Phospho-PKB (Ser%($) (Cell Signaling Technology) or PKB-specific antibodies (Santa Cruz) were used at a dilution of 1 : 2000. Proteins were detected using the ECL2 chemiluminescence system (Amersham Pharmacia Biotech).
Animals
Sprague-Dawley rats weighing 120 g were used. After 24 h of starvation, the rats were intraperitoneally injected with wortmannin in a 4 % methanol-saline solution (1.4 mg\kg) or with vehicle. After 15 min, the rats were injected intraperitoneally with human insulin (100 UI\kg) (Actrapid ; Novo-Nordisk, Copenhagen, Denmark) or with saline solution and they were killed 1 h later.
RNA-blot analysis
Total RNA was prepared from rat liver by extraction with guanidine isothiocyanate and centrifugation through a CsCl cushion [31] . Aliquots (15 µg) of RNA (determined at A #'! ) were fractionated on 1 % (w\v) agarose\formaldehyde gels, transferred on to Nytran-N membranes (Schleicher & Schuell) and UV cross-linked. Hybridizations were performed as described previously [31] , with a 1.1 kb-specific fragment of the rat HMGCS2 cDNA or with a 600 bp-specific fragment of human β-actin cDNA. Washes were performed either at 65 or 55 mC with 0.1iSSC and 0.1 % SDS respectively. A 1 h exposure of this blot was analysed with a STORM 840 laser scanning system (Amersham Pharmacia Biotech).
RESULTS

The rat HMGCS2 gene is inhibited by insulin
We aimed to measure the effect of insulin on the transcriptional activity of the HMGCS2 gene. Therefore we transiently co-transfected HepG2 cells with the reporter plasmid pGL3SM1 (a reporter construct containing the luciferase gene under the control of the 5h-flanking region of the HMGCS2 gene promoter from k1148 to j28), together with an expression vector for the insulin receptor B. Cells were incubated for 18-20 h with 10 nM insulin, and luciferase activity was determined as indicated in the Experimental section. As shown in Figure 1(A) , insulin halves the activity of HMGCS2. On incubation with increasing amounts of insulin, this transcriptional repression was found to increase until reaching a maximum at 10 nM insulin but did not increase at higher concentrations ( Figure 1B ). Therefore we used 10 nM insulin for the rest of the experiments.
Transcriptional activation of the HMGCS2 gene by FKHRL1 : localization of the target site
As FKHRL1 binds to the IRE in various promoters, we tested whether it affects the HMGCS2 gene in transient transfection experiments. HepG2 cells were co-transfected with an FKHRL1 expression plasmid and an HMG-CoA promoter-CAT reporter plasmid (pSMpCAT1, a reporter construct containing the CAT gene under the control of the 5h-flanking region of the HMGCS2 gene promoter from k1148 to j28). FKHRL1 increased the HMGCS2 promoter activity by 4 -5-fold. To locate the control elements that mediate the effects of FKHRL1, we used several chimaeric constructs carrying progressively larger 5h-deletions of the 5h-flanking region of the mitochondrial synthase gene promoter upstream of the CAT gene. The transcriptional activity of these constructs was tested in the presence or absence of the FKHRL1 expression vector. As shown in Figure 2 (A), deletion of nucleotides up to position k333 did not compromise the response to FKHRL1, which was greatly diminished by further deletion up to nucleotide k116. Therefore the promoter region between k333 and k116 from the transcription start site was essential for FKHRL1-induced transcription. When this region was analysed, the nucleotide sequence from k211 to k205 showed a perfect match with a binding site for members of the forkhead family of transcription factors. These results are consistent with previous ' fingerprint ' data on the binding of nuclear liver proteins in the same region (results not shown).
The k211 to k205 region of HMGCS2 gene promoter binds to members of the forkhead family of transcription factors
The binding of FKHRL1 to the HMGCS2 gene promoter was confirmed by EMSA. FKHRL1 transcribed and translated in itro was incubated with a labelled fragment containing the putative IRS. Under these conditions, a major complex was observed (Figure 3, lanes 3 and 10) . Its specificity was assayed by competition with a 50-, 100-and 200-fold molar excess of unlabelled IRS (Figure 3, lanes 11-13) . The identity of the protein in the complex was confirmed by supershift experiments with an antibody raised against FKHRL1, which clearly decreased the formation of the specific complex ( Figure 3, lane 4) . Mutation of the proposed FKHRL1 binding site obliterates the binding of this transcription factor to the probe (IRSmut) (Figure 3,  lanes 5 -7) .
Endogenous FKHRL1 binds to the HMGCS2 IRS gene promoter
To study whether endogenous FKHRL1 binds to the proposed HMGCS2 IRS, we performed a ChIP assay in which chromatin was precipitated with a specific antibody raised 
Mutation of the HMGCS2 IRS partially suppresses the insulin-mediated repression of basal and FKHRL1-activated transcription
Next, we studied whether the insulin effect was mediated by the IRS element described in the HMGCS2 promoter. HepG2 cells were co-transfected with an expression vector for the insulin receptor B and the reporter plasmids pGL3SM1 or pGL3SM1-IRSmut (a construct in which the IRS was altered by mutation) and incubated with 10 nM insulin. This mutation partially inhibited the response to insulin ( Figure 5A ). It also repressed the activation of the HMGCS2 gene by FKHRL1 ( Figure 5B ). Given that insulin repression and FKHRL1 activation were localized at the same responsive element, we studied whether insulin modifies the activity of FKHRL1. The effect of FKHRL1 on the HMGCS2 promoter was inhibited by incubating transfected cells with 10 nM insulin ( Figure 5B ), indicating that both signals belong to the same pathway. Down-regulation of the HMGCS2 gene by insulin 
The proposed IRS confers FKHRL1 and insulin responsiveness to a heterologous promoter
A pair of oligonucleotides containing one copy of the mitochondrial synthase IRS was inserted into TKLUC, a plasmid containing the luciferase gene under the control of the thymidine kinase gene promoter. As shown in Figure 6 , this element The results of luciferase activities (meanspS.D.), corrected for the protein concentration in the cell lysate, from at least three independent experiments with two plates each, are expressed as arbitrary units of luciferase activity. Statistical analysis of the data confirmed that the increase in transcriptional activity caused by FKHRL1 and the repression caused by insulin on the wildtype construct were significant (*P 0.05 compared with the luciferase activity of the wild-type construct ; ¶P 0.05 compared with the activation produced by the FKHRL1 transcription factor).
conferred FKHRL1 and insulin responsiveness on the otherwise unresponsive thymidine kinase gene promoter, confirming that it is essential for the inhibition of the FKHRL1-stimulated HMGCS2 promoter by insulin.
PI-3K mediates the inhibition of HMGCS2 transcription by insulin
Since many of the metabolic activities of insulin can be mediated by a protein kinase cascade that lies downstream of PI-3K, we studied whether the PI-3K transduction pathway was involved in the insulin-mediated transcriptional repression of the HMGCS2 gene. HepG2 cells were transfected with the reporter plasmid pGL3SM1 and incubated with insulin and the PI-3K-specific inhibitors, LY294002 (25 µM) and wortmannin (200 nM), as indicated in Figures 7(A) and 8(A) . The presence of the PI-3K inhibitors abolishes the response to insulin, revealing the PI-3K participation in the insulin repression of HMGCS2. We aimed at showing that the concentration of inhibitor used to block the transcriptional repression of the HMGCS2 gene by insulin was able to inhibit effectively insulin-induced activation of PI-3K\Akt. Therefore we performed Western-blot assays with a phospho-PKB (Ser%($) antibody on HepG2 cell extracts incubated with insulin in the presence or absence of LY294002, as indicated in Figure 7 (B). To study the in i o role of the PI-3K transduction pathway in the insulin-mediated transcriptional repression of the HMGCS2 gene, starved rats were treated with insulin or insulin plus wortmannin and the total liver mRNA was analysed by Northern blotting. As shown in Figures 8(B) and 8(C), insulin represses HMGCS2 mRNA expression in i o, whereas this repression is abolished in the presence of wortmannin. This result confirms the correlation between the in itro results and the in i o situation.
PKB is able to repress both basal and FKHRL1-induced transcriptional activities of the HMGCS2 gene
To confirm the role of PKB activation in the control of HMGCS2 gene expression, we co-transfected HepG2 cells with a luciferase construct, together with an expression vector for an active or a kinase dead form of PKB and FKHRL1. As shown in Figure 9 , PKB represses both basal and FKHRL1-induced transcriptional activities of the HMGCS2 gene, whereas the expression of the kinase dead form of PKB does not affect either basal or induced promoter activity. This result confirms the role of PKB in the insulin-induced repression of HMGCS2 gene transcription.
A non-phosphorylatable mutant version of FKHRL1 binds to IRS and transactivates the HMGCS2 gene but is less responsive to insulin than the wild-type form
We aimed at verifying whether the repression of the HMGCS2 promoter by insulin involves the phosphorylation of FKHRL1 by PKB\Akt. Therefore we co-transfected HepG2 cells with the reporter pGL3SM1 and an expression vector for FKHRL1 or a non-phosphorylatable mutant of this transcription factor (FKHRL1TM) and incubated the cells either in the presence or absence of insulin. In cells transfected with the mutant FKHRL1, the response to insulin was partially decreased, suggesting that phosphorylation of FKHRL1 by PKB mediates the transcriptional response to insulin ( Figure 10A ). This mutant can bind to the same sequence as the wild-type factor ( Figure 10B ).
DISCUSSION
HMGCS2 is a key enzyme that controls ketogenesis in certain metabolic situations, thus the mRNA and protein levels of HMGCS2 are increased during streptozotozin-induced diabetes and starvation, and these changes are counteracted by insulin or refeeding [5] . We have shown that insulin suppresses HMGCS2 promoter activity. This effect requires a forkhead-binding site in the 5h-flanking region of the gene, in which a mutation partially impairs the inhibition of both basal and FKHRL-induced transcriptional activities by insulin. This sequence binds both in i o and in itro to FKHRL1. The present study has also shown that both a mutated form of FKHRL, which cannot be phosphorylated by PKB, and the PI-3K inhibitors LY294002 and wortmannin abolish the regulation of the HMGCS2 promoter by insulin. Our data provide further evidence of the role of the phosphorylation of the forkhead proteins by PKB in the regulation of glucose homoeostasis, which can also be applied to ketogenesis.
We first showed that insulin inhibits HMGCS2 gene transcriptional activity in a dose-dependent manner to a maximum of approx. 50 % of the activity observed in the absence of insulin. Similar repression levels for other insulin-regulated genes have been reported previously [19] .
Members of the FKHR subclass of the Fox family of transcription factors are involved in the regulation of gene expression by insulin [21] [22] [23] 25] . Therefore we studied whether they also participate in the transcriptional repression of the rat HMGCS2 gene by insulin. FKHRL1 stimulates transcription from transfected HMGCS2 promoter-luciferase reporter constructs. We mapped the sequence responsible for this induction ; by deletion analysis and mutation experiments, we showed that the sequence AAAAATA, located 211 bp upstream of the HMGCS2 gene transcription start site, binds to FKHRL1 in itro and that it confers FKHRL1 responsiveness on the homologous and heterologous promoters. The same results were obtained with FKHR, another member of this subfamily of the forkhead family of transcription factors (results not shown). This stimulation is repressed by insulin. Mutation of this sequence partially abolishes the effect of insulin both in the absence or presence of overexpressed FKHRL1. Moreover, ChIP demonstrates that in HepG2 cells without overexpression of FKHRL1, it binds to the HMGCS2 gene promoter in its natural context. This result supports all in itro experiments and includes physiological evidence for the role of forkhead transcription factors in the transcriptional regulation of the HMGCS2 gene. All the above results suggest that FKHRL1 contributes to the regulation of HMGCS2 gene expression by insulin, although the participation of other factors and the presence of other cis-acting sequences cannot be ruled out.
We used different approaches to address the contribution of the phosphorylation of forkhead proteins through the PI-3K\Akt transduction pathway to the effects of insulin on the transcriptional activity of the HMGCS2 gene. Firstly, the presence of different PI-3K-specific inhibitors, such as LY294002 and wortmannin, completely block the effect of insulin on HMGCS2 gene transcription in HepG2-transfected cells, and intraperitoneally injected wortmannin also blocks the insulin-induced repression of HMGCS2 mRNA. The involvement of PI-3K\Akt is reinforced by the results of Western-blot experiments showing that LY294002, at the concentration used in the present study, effectively blocks insulin-induced activation of PI-3K\Akt, parallel with the inhibition of insulin-mediated transcriptional repression of the HMGCS2 gene. Secondly, overexpression of an active form of PKB\Akt, which is a downstream PI-3K target in the insulin-signalling pathway, significantly represses both basal and FKHRL1-induced transcriptional activities of the HMGCS2 gene, whereas a kinase dead form of PKB does not. Thirdly, overexpression of a mutant FKHRL1 that cannot be phosphorylated by PKB partially suppresses inhibition by insulin, which supports the idea that phosphorylation of FKHRL1 by insulinactivated PKB mediates the inhibition of HMGCS2 gene transcription by insulin. Together, these results suggest that signalling via the PI-3K\PKB\forkhead transcription factor pathway is involved in the regulation of this gene by insulin. However, as the activation produced by the overexpression of this non-phosphorylable mutant is still partially suppressed by insulin, other pathways may also be involved. Forkhead proteins regulate the transcription of several genes associated with the homoeostasis of glucose (this activity is suppressed by insulin), e.g. the IGFBP-1 gene [33, 34] , which is thought to maintain glucose homoeostasis by inhibiting the insulin-like effects of IGF-I and IGF-II, and the gluconeogenic genes phosphoenolpyruvate carboxykinase (PEPCK) [35] and glucose-6-phosphatase [36] . All these genes contain an IRE that binds forkhead proteins [19, [21] [22] [23] 25, 26] . Overexpression of FKHR proteins in cells leads to a stimulation of the reporter constructs driven by the promoter of these genes, and this transactivation is blocked by insulin [21, 23, 25, 26] . Although the forkhead proteins are involved in all cases, it has been found that in the case of IGFBP-1, but not glucose-6-phosphatase or PEPCK, mTOR is required for the full insulin regulation of gene transcription [24] . The role of FKHRL1 in the insulin-mediated inhibition of gene transcription has been challenged by experiments with PEPCK and IGFBP-1 IREs [26] . These experiments have shown that although FKHRL1 binds in itro to these sequences and activates transcription through these elements, the specific point mutations in these IREs that abolish insulin repression of transcription do not affect the binding of FKHRL1 to these sequences in itro. Still, it is possible that FKHRL1 is the IRE-specific factor, and differences between in i o and in itro binding to DNA could explain those results. Nevertheless, the in i o binding of FKHRL1 to the IRS sequence is well demonstrated in the present study. The ChIP assay confirms that endogenous HepG2 FKHRL1 occupies the HMGCS2 gene promoter in its natural context.
The present study supports the role of forkhead proteins in the regulation of another gene associated with glucose homoeostasis, namely HMGCS2. This enzyme has been proposed as a key control site in the ketogenesis pathway, which produces ketone bodies that can be used as a metabolic fuel during catabolic states such as starvation and diabetes. We have identified an IRS in the 5h-flanking region of this gene that contributes to the repression of transcription induced by insulin in HepG2 cells, although we cannot rule out the participation of other cis elements or the binding of other trans-acting factors. Also, since our expression studies were performed in the HepG2 cell line, further studies in hepatocytes may be required to investigate the physiological significance of these findings.
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